Significance of LIF/LIFR Signaling in the Progression of Obesity-Driven Triple-Negative Breast Cancer is a research paper published in Cancers (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R01CA267893
NIH
Grant: IRG-21-147-01-IRG
NIH
Grant: CA266970-01A1
NIH
Grant: CA277164-01A1
NIH
Grant: BX006280-0 1
NIH
Grant: CA265339
NIH
Grant: CA054174
NIH
Grant: 1S10 OD030311-01
Illumina NovaSeq 6000 Sequencing System
NIH
Grant: RP220662
BLRD VA
Grant: I01 BX006280
NCI NIH HHS
Grant: P30 CA054174
NCI NIH HHS
Grant: R21 CA277164
NIH HHS
Grant: S10 OD030311
NCI NIH HHS
Grant: R01 CA266970
NCI NIH HHS
Grant: R50 CA265339
ACS pilot grant
Grant: t IRG-21-147-01-IRG
National Institutes of Health
Grant: 1R50CA265339-01A1
Advancing Cancer Research Through Next Generation Sequencing at Mays Cancer Center of UT Health San Antonio
National Institutes of Health
Grant: 5P30CA054174-16
SAN ANTONIO CANCER INSTITUTE
National Institutes of Health
Grant: 5R01CA266970-02
Novel targeted therapy for treating Ovarian Cancer
National Institutes of Health
Grant: 5R21CA277164-02
Targeting the RNA modifying enzyme ALKBH5 in Medulloblastoma
National Institutes of Health
Grant: 4R01CA267893-04
Development of new therapeutic approaches for endometrial cancer
UT Health San Antonio
Bank of America
Fields of Study
Keywords